NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.
NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.
Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.
FDA says new tools needed to speed therapeutics development.
Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.
CDC study finds obesity may become leading preventable cause of death; NIH research plan drafted.
Funding opportunities listed.
Trending Stories
- Trump 2016: A look back at the 45th president’s impact on oncology
- Betty Ford and the press conference that changed oncology
- David Lauren: We’re focused on cancer. This isn’t about just sending a check. This is our mission.
- The unKOOL, unfiltered history of menthol cigarettes
- Should you eat a kielbasa tonight?
Six experts weigh evidence on papers debunking nutritional guidelines on red and processed meat - What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”